Helena Shomar Monges

Title: Helena Shomar Monges: Innovator in Anti-Viral and Anti-Tumoral Compounds

Introduction

Helena Shomar Monges is a prominent inventor based in Tel Aviv, Israel. She has made significant contributions to the field of pharmaceuticals, particularly in developing compounds that target viral and tumoral diseases. Her innovative work has the potential to impact the treatment of various serious health conditions.

Latest Patents

Helena holds 1 patent for her invention titled "Anti-viral and anti-tumoral compounds." This patent discloses 3,4-didehydro- and 3'-deoxy-3,4-didehydro-compounds along with their pharmaceutical compositions. The methods of use for these compositions include treating diseases such as virus-induced diseases, cancer, autoimmune diseases, immune disorders, and bacterial-associated infections. Notably, her research addresses viral infections caused by RNA or DNA viruses, including SAR-CoV-2, EBV, BKV, JCV, and HCMV.

Career Highlights

Helena has established herself as a key figure in her field through her innovative research and development efforts. Her work at Yeda Research and Development & Co. Ltd. has positioned her at the forefront of pharmaceutical innovation. She is dedicated to advancing medical science and improving patient outcomes through her discoveries.

Collaborations

Helena collaborates with talented professionals in her field, including Lianet Noda Garcia and Arthur Machlenkin. These partnerships enhance her research capabilities and contribute to the success of her projects.

Conclusion

Helena Shomar Monges is a trailblazer in the development of anti-viral and anti-tumoral compounds. Her contributions to pharmaceutical science are noteworthy and hold promise for future medical advancements.